SpyGlass Pharma Inc

Research SpyGlass Pharma Inc (SGP) on Bullrun: market cap USD 723.82M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSGP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 723.82M
• Financial periodFY2025
• Net income-USD 39.87M
• Free cash flow-USD 33.49M

Valuation Snapshot

latest market cap is USD 723.82M.

About SpyGlass Pharma Inc

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients.

Frequently asked questions

What is SpyGlass Pharma Inc's market cap?

SpyGlass Pharma Inc's market capitalization is USD 723.82M.

What does SpyGlass Pharma Inc do?

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.